| Entry |
|
|---|
| Name |
Hyperlipoproteinemia, type V
|
|---|
| Description |
Type V hyperlipoproteinemia is an autosomal recessive disorder caused by deficiency of apolipoprotein A-V and characterized by an increase of chylomicrons and VLDL and a decrease of LDL and HDL in the plasma after a fast.
|
|---|
| Category |
Inherited metabolic disease
 |
|---|
| Pathway |
|
|---|
| Gene |
|
|---|
| Marker |
chylomicron
VLDL
|
|---|
| Drug |
|
|---|
| Other DBs |
|
|---|
| Reference |
|
|---|
| Authors |
Calandra S, Priore Oliva C, Tarugi P, Bertolini S |
|---|
| Title |
APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. |
|---|
| Journal |
Curr Opin Lipidol 17:122-7 (2006) |
|---|
| Reference |
|
|---|
| Authors |
Rensen PC, van Dijk KW, Havekes LM |
|---|
| Title |
Apolipoprotein AV: low concentration, high impact. |
|---|
| Journal |
Arterioscler Thromb Vasc Biol 25:2445-7 (2005) |
|---|
